Description:
CARBAMOYL PHOSPHATE SYNTHETASE I DEFICIENCY
Repository
|
NIGMS Human Genetic Cell Repository
|
Subcollection |
Heritable Diseases Disorders of the Urea Cycle |
Class |
Disorders of Amino Acid Metabolism |
Cell Type
|
Fibroblast
|
Transformant
|
Untransformed
|
Race
|
White
|
Relation to Proband
|
proband
|
Confirmation
|
Clinical summary/Case history
|
Species
|
Homo sapiens
|
Common Name
|
Human
|
Remarks
|
|
Passage Frozen |
5 |
|
IDENTIFICATION OF SPECIES OF ORIGIN |
Species of Origin Confirmed by Nucleoside Phosphorylase Isoenzyme Electrophoresis |
|
carbamoyl-phosphate synthetase |
According to the submitter, biochemical test results for this subject showed decreased enzyme activity. EC Number: 6.3.4.16 |
|
Remarks |
Onset of lethargy & vomiting at age 3 weeks; severe mental retardation; growth retardation; CPS deficiency confirmed by liver biopsy |
Batshaw M, Brusilow S, Walser M, Treatment of carbamyl phosphate synthetase deficiency with keto analogues of essential amino acids. N Engl J Med292:1085-90 1975 |
PubMed ID: 165404 |
Passage Frozen |
5 |
Split Ratio |
1:4 |
Temperature |
37 C |
Percent CO2 |
5% |
Medium |
Eagle's Minimum Essential Medium with Earle's salts and non-essential amino acids with 2mM L-glutamine or equivalent |
Serum |
15% fetal bovine serum Not inactivated |
Substrate |
None specified |
Subcultivation Method |
trypsin-EDTA |
Supplement |
- |
|
|